Literature DB >> 28321600

Post 6-OHDA lesion exposure to stress affects neurotrophic factor expression and aggravates motor impairment.

Phumzile Nomfundo Ngema1, Musa Vuyisile Mabandla2.   

Abstract

Chronic exposure to stress amplifies locomotor deficits and exacerbates dopamine neuron loss in an animal model for Parkinson's disease. The release of neurotrophic factors such as glial cell-line derived neurotrophic factor (GDNF) and neurotrophin-3 (NT-3) following neuronal injury attenuates exacerbated degeneration of these neurons. In this study, the neurotoxin 6-hydroxydopamine (6-OHDA) was injected unilaterally into the medial forebrain bundle of male Sprague Dawley rats. A subset of these rats was subjected to post-lesion restraint stress after which the effect of exposure to stress on locomotor activity (forelimb akinesia test), neurotrophic factor (GDNF and NT-3) and corticosterone concentration was assessed. Exposure to post-lesion stress resulted in increased preference to use the unimpaired forelimb (forelimb ipsilateral to the lesioned hemisphere) in the forelimb akinesia test. The expected increase in both GDNF and NT-3 concentration following injury was not present in the stressed animals. However, both the non-stressed and stressed lesioned groups had decreased neurotrophic factor concentration at one and two weeks post lesion. This decrease was exaggerated in the stressed rats. The decrease in neurotrophic factor concentration was accompanied by an increase in corticosterone concentration in the stressed rats. These findings demonstrate that exposure to post-6-OHDA lesion stress exaggerates dopamine neurodegeneration and enhance motor impairment. This suggests that conditions that result in a hyper-activated hypothalamic-pituitary-adrenal axis such as depression which is concomitant to a Parkinson's disease diagnosis may be responsible for enhanced dopamine depletion by attenuating neurotrophic factor concentration elevation in the nigrostriatal pathway following neuronal injury.

Entities:  

Keywords:  6-hydroxydopamine; Corticosterone; Neurotrophic factors; Parkinson’s disease; Post-lesion stress

Mesh:

Substances:

Year:  2017        PMID: 28321600     DOI: 10.1007/s11011-017-9988-1

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  35 in total

1.  Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites.

Authors:  Andreas Heuer; Gaynor A Smith; Mariah J Lelos; Emma L Lane; Stephen B Dunnett
Journal:  Behav Brain Res       Date:  2011-11-28       Impact factor: 3.332

Review 2.  Effects of stress throughout the lifespan on the brain, behaviour and cognition.

Authors:  Sonia J Lupien; Bruce S McEwen; Megan R Gunnar; Christine Heim
Journal:  Nat Rev Neurosci       Date:  2009-04-29       Impact factor: 34.870

Review 3.  Neurotrophic factors for the treatment of Parkinson's disease.

Authors:  Aideen M Sullivan; André Toulouse
Journal:  Cytokine Growth Factor Rev       Date:  2011-06       Impact factor: 7.638

4.  Effectiveness of different corticosterone administration methods to elevate corticosterone serum levels, induce depressive-like behavior, and affect neurogenesis levels in female rats.

Authors:  J M Kott; S M Mooney-Leber; F A Shoubah; S Brummelte
Journal:  Neuroscience       Date:  2015-11-10       Impact factor: 3.590

5.  Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.

Authors:  X Jing; H Shi; C Zhang; M Ren; M Han; X Wei; X Zhang; H Lou
Journal:  Neuroscience       Date:  2014-11-29       Impact factor: 3.590

6.  Moderate treadmill exercise rescues anxiety and depression-like behavior as well as memory impairment in a rat model of posttraumatic stress disorder.

Authors:  Gaurav Patki; Lumeng Li; Farida Allam; Naimesh Solanki; An T Dao; Karim Alkadhi; Samina Salim
Journal:  Physiol Behav       Date:  2014-03-19

Review 7.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

Review 8.  Treatment of Parkinson's disease with trophic factors.

Authors:  Amie L Peterson; John G Nutt
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 9.  Stress-induced Parkinson's disease: a working hypothesis.

Authors:  Amanda D Smith; Sandra L Castro; Michael J Zigmond
Journal:  Physiol Behav       Date:  2002-12

Review 10.  Nicotine neuroprotection against nigrostriatal damage: importance of the animal model.

Authors:  Maryka Quik; Michael O'Neill; Xiomara A Perez
Journal:  Trends Pharmacol Sci       Date:  2007-04-06       Impact factor: 14.819

View more
  1 in total

1.  Blueberry juice augments exercise-induced neuroprotection in a Parkinson's disease model through modulation of GDNF levels.

Authors:  Sandra L Castro; Victor Tapias; Ronald Gathagan; Alexandra Emes; Taylor E Brandon; Amanda D Smith
Journal:  IBRO Neurosci Rep       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.